Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL) (ANCHOR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01047501
Recruitment Status : Completed
First Posted : January 13, 2010
Last Update Posted : November 27, 2013
Information provided by (Responsible Party):
Amarin Pharma Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2011
  Study Completion Date : No date given
  Certification/Extension First Submitted : October 10, 2013